- Confidentially assess their own disability and veteran employment practices
- Benchmark their efforts against leading practices; and
- Use results to educate internal stakeholders on successes and opportunities
Exelon's (EXC) stock price target was reduced to $39 from $41 at Barclays on Wednesday morning.
Exelon is moderately cheap compared with the industry while Sempra and Dominion may be gaining some traction, analysts say.
Exelon (EXC) is buying a nuclear plant in New York State from Entergy (ETR) for $110 million.